The below suggests as of September 2023 Charac has received...

The below suggests as of September 2023 Charac has received total funding of £2.5M.

https://www.pharmacymagazine.co.uk/news/npa-and-others-put-12m-funding-into-charac-pharmacy-app

Two months later MedAdvisor announce they are investing £1M to hold 7.4% of Charac.

This would suggest Charac would be valued at £13.5M or AU$26M.

Target numbers in the article is 5x growth in pharmacies using the software (400 to 2000) from 2023 to 2024 and 4x growth in customers (from 25,000 to 100,000) by March 2024.

Big numbers if true. Hopefully there's more media on Charac to track progress.

I'd like to see a bit more on Charac in the March quarter update.

We're half way through Q3. Management have shown to announce ranged forecasts with official numbers exceeding their projection.

Daily up/down selling/buying is chicken feed with a volume CXA cross trade thrown in.

I doubt we'll get anything until the next 4C so hope the share price holds up.

Still a sleeper.........